Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Dec;157(12):2875.
doi: 10.1097/j.pain.0000000000000713.

A tale of 2 ADFs-with 2 different abuse-deterrent formulations

J David Haddox  1 , Richard O Mannion  2
Affiliations
Comment

A tale of 2 ADFs-with 2 different abuse-deterrent formulations

J David Haddox et al. Pain. 2016 Dec.
No abstract available

PubMed Disclaimer

Comment in

  • Reply.
    Cicero TJ, Ellis MS, Kasper ZA. Cicero TJ, et al. Pain. 2016 Dec;157(12):2875-2876. doi: 10.1097/j.pain.0000000000000712. Pain. 2016. PMID: 27841841 No abstract available.

Comment on

References

    1. Cicero TJ, Ellis MS, Kasper ZA. A tale of 2 ADFs: differences in the effectiveness of abuse-deterrent formulations of oxymorphone and oxycodone extended-release drugs. PAIN 2016;157:1232–8.
    1. Endo Pharmaceuticals Inc. OPANA ER with INTAC. Available at: http://www.opana.com/prescriber/product-information/intac-extended-relea.... Accessed August 8, 2016.
    1. Kraus A, Wening K, Schwier S, Stahlberg H-J, Galia E, Sokolowska M. Expanding hot-melt extrusion based abuse-deterrent formulation technology from extended release (ER) to immediate release (IR) application. Aachen, Germany: Grünenthal GmbH. Available at: http://www.intac.grunenthal.com/cms/cda/_common/inc/display_file.jsp?fil.... Accessed August 8, 2016.
    1. Mastropietro DJ, Omidian H. Abuse-deterrent formulations: part 2: commercial products and proprietary technologies. Expert Opin Pharmacother 2015;16:305–23.
    1. McKenna WH, Mannion RO, O'Donnell EP, Huang HH. (2014) US Patent No. 8,808,741: tamper resistant dosage forms. Washington, DC: US Patent and Trademark Office.

MeSH terms

Substances

LinkOut - more resources